Legal & General Group
VTYX

Legal & General Group’s Ventyx Biosciences VTYX Stock Holding History

Legal & General Group’s Portfolio VTYX Stock Details VTYX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-5,981
Closed -$6.91K – 3553
2025
Q1 		$6.91K Hold
5,981
– – ﹤0.01% 3237
2024
Q4 		$13.1K Hold
5,981
– – ﹤0.01% 3181
2024
Q3 		$13.1K Hold
5,981
– – ﹤0.01% 3208
2024
Q2 		$13.8K Sell
5,981
-635
-10% -$2.64K ﹤0.01% 3183
2024
Q1 		$36.3K Sell
6,616
-35,888
-84% -$164K ﹤0.01% 2820
2023
Q4 		$105K Sell
42,504
-39
-0.1% -$370 ﹤0.01% 2761
2023
Q3 		$1.48M Buy
42,543
+5,716
+16% +$198K ﹤0.01% 2033
2023
Q2 		$1.21M Buy
36,827
+26,254
+248% +$905K ﹤0.01% 2144
2023
Q1 		$354K Buy
10,573
+3,191
+43% +$124K ﹤0.01% 2415
2022
Q4 		$242K Buy
7,382
+4,689
+174% +$139K ﹤0.01% 2538
2022
Q3 		$94K Buy
2,693
+271
+11% +$6K ﹤0.01% 2844
2022
Q2 		$30K Buy
2,422
+1,462
+152% +$21.8K ﹤0.01% 3117
2022
Q1 		$13K Hold
960
– – ﹤0.01% 3343
2021
Q4 		$19K Buy
+960
New +$18.2K ﹤0.01% 3296

Other funds holding VTYX

Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return

Legal & General Group's VTYX Position: Q2 2025 in Review

Legal & General Group sold out of Ventyx Biosciences (VTYX) in Q2 2025, closing a stake of 5,981 shares — an estimated $6.91K sold.

Legal & General Group first reported a position in VTYX in Q4 2021 and held it in 14 quarters. The position peaked at $1.48M in Q3 2023. 114 funds tracked by Wall St. Rank hold VTYX as of Q2 2025.

  • Legal & General Group reported no remaining Ventyx Biosciences position as of Q2 2025 after selling out during the quarter.
  • Legal & General Group sold 5,981 Ventyx Biosciences shares in Q2 2025, an estimated $6.91K.
  • Legal & General Group first reported a position in Ventyx Biosciences in Q4 2021 and held it in 14 quarters.
  • Legal & General Group's Ventyx Biosciences position peaked at $1.48M in Q3 2023.
  • 114 funds tracked by Wall St. Rank held Ventyx Biosciences as of Q2 2025.

Based on Legal & General Group's 13F filing for Q2 2025, filed 12 Aug 2025.